Location out of bounds
Researcher handling test tubes.

Great Lakes Translational Glycomics Symposium

Featuring a day of thought leaders working in the glycosciences.

Contact

Anna Schmidt

Email

Heparin Induced Thrombocytopenia (HIT): How Can Emerging Glycotechnologies be Used to Address This Pressing Clinical Problem?

August 26, 2021 | Virtual Event 8 a.m. - 12 p.m.


The Blood Research Institute in collaboration with its K12 Clinical Scholars Program (https://www.translationalglycomics.com) participants will host a unique virtual workshop on August 26, 2021 focused on heparin induced thrombocytopenia (HIT). The Workshop endeavors to bring clinicians, glycobiologists, and technologists together with the overarching goal to stimulate actionable ideas at to improve our understanding of HIT and drive next generation prediction, diagnostic, and treatment modalities.

This event will be hosted by:
The Blood Research Institute

Unique and Innovative workshop suited for those with limited time:

  • View pre-recorded overviews by our speakers at any time (available online)
  • Tune in on symposium day 8/26 8 a.m. - 12 p.m. CT for live short talks and interactive discussion with our panelists

2021 Featured Speakers

The Workshop will include lectures from the following four members of the glycobiology community.
 

Dr. Umesh Desai, Ph.D.

Dr. Umesh Desai, Ph.D.
Virginia Commonwealth University

Heparin - Protein Interactome Using Computational Methods

Dr. Desai’s research interests are in biophysical studies of heparin and the heparin-mimetic drug development.


Dr. Adam Hawkridge, Ph.D.

Dr. Adam Hawkridge, Ph.D.
Virginia Commonwealth University

Unraveling heparin-protein interactions with mass spectrometry

Dr. Hawkridge’s research interests are in glycoanalytical technology development.


Dr. Anand Padmanabhan, M.B.B.S., Ph.D.

Dr. Anand Padmanabhan, M.B.B.S., Ph.D.
Mayo Clinic

Heparin-induced thrombocytopenia: New approaches to Pathophysiology & Diagnosis

Dr. Padmanabhan’s research interests are in platelet immunology and HIT.


Dr. Demin Wang, Ph.D.

Dr. Demin Wang, Ph.D.
Blood Research Institute

Atypical antibody response in heparin-induced thrombocytopenia

Dr. Wang’s research interests are in hematopoiesis and immunology.

Moderators: Dr. Adam Hawkridge, Ph.D. and Dr. Melissa Lee-Sundlov, Ph.D.


Event Information


Workshop attendees will be provided access to pre-recorded lectures (45-60 minutes each) from all four investigators that provide background information on clinical and biological aspects of HIT, heparin structure, and emerging glycotechnologies.

These pre-recorded videos will be available several weeks in advance of the Workshop and can be viewed at any time. During the August 26th Workshop, the four speakers will give more focused research talks that build on the pre-recorded lectures and focus on specific aspects of HIT. Finally, ample time is provided for engaging discussions related to improving HIT outcomes. Participants can expect learn the following from the Workshop:
 

  1. Current clinical management of HIT
  2. HIT mechanism(s)
  3. Structural details of heparin and endogenous heparan sulfate
  4. Heparin-protein interactions
  5. Mass spectrometry-based glycomics approaches to characterizing heparin

Pre-Workshop Videos


As an attendee, you have access to pre-recorded lectures from experts in heparin-induced thrombocytopenia (HIT).
 

Versiti Organizing Committee Chair:

Karin Hoffmeister, MD

Karin Hoffmeister, M.D.
khoffmeister@versiti.org

Versiti Organizing Committee Co-Chair:

Adam Hawkridge, Phd

Adam Hawkridge, Ph.D.

Versiti Organizing Committee Member:

Melissa Lee-Sundlov, Ph.D.

Melissa Lee-Sundlov, Ph.D.
MLeeSundlov@Versiti.org

x

This website uses cookies to ensure you get the best experience on our website. Learn more